Outcomes from leiomyoma therapies: comparison with normal controls
- PMID: 21422876
- DOI: 10.1097/AOG.0b013e3182114e36
Outcomes from leiomyoma therapies: comparison with normal controls
Comment on
-
Outcomes from leiomyoma therapies: comparison with normal controls.Obstet Gynecol. 2010 Sep;116(3):641-652. doi: 10.1097/AOG.0b013e3181ed36b3. Obstet Gynecol. 2010. PMID: 20733447
References
-
- Spies JB, Bradley LD, Guido R, Maxwell GL, Levine BA, Coyne K. Outcomes from leiomyoma therapies: comparison with normal controls. Obstet Gynecol 2010;116:641–52.
-
- Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, et al. Hysterectomy surveillance–United States, 1980–1993. MMWR CDC Surveill Summ 1997;46:1–15.
-
- Shankar M, Chi C, Kadir RA. Review of quality of life: menorrhagia in women with or without inherited bleeding disorders. Haemophilia 2008;14:15–20.
-
- Munro MG, Critchley HOD, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravidwomen of reproductive age. Int J Gynecol Obstet 2011;113(1).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical